Neoplams
13
4
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (13)
Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
Using Virtual Reality During PICC and PICC-PORT Placement in Cancer Patients
Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
One-Page Truth-Telling Aid for Cancer Disclosure
The Effect of Isometric Exercise and Dry Heat Application on PIVC
Pilot Feasibility Study of a Dyadic Culinary Nutrition Intervention
Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors
xDRIVE for Florida-based Cancer Patients
The Phase I Study of SIG001 Antibody on Cancer Therapy.
Plyometric Strength-Endurance Exercise in Breast Cancer
Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum
Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies
Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients